[Electrophysiologic effects of intravenous dauricine on accessory pathway in Wolff-Parkinson-White syndrome].
Liu
Y W
YW
Mao
H Y
HY
Guo
J H
JH
D000293:Adolescent; D000328:Adult; D000368:Aged; D000470:Alkaloids; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D044182:Benzylisoquinolines; D004562:Electrocardiography; D005260:Female; D006329:Heart Conduction System / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D007546:Isoquinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D044005:Tetrahydroisoquinolines; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy / Q000503:physiopathology*
D000470:Alkaloids; D000889:Anti-Arrhythmia Agents; D044182:Benzylisoquinolines; D007546:Isoquinolines; D044005:Tetrahydroisoquinolines; C035934:dauricine